Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,411 | 283 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,354 | 49 | $0 (2024) |
| Biogen, Inc. | $1,138 | 50 | $0 (2024) |
| Lilly USA, LLC | $549.41 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $295.02 | 21 | $0 (2024) |
| Lundbeck LLC | $249.75 | 15 | $0 (2024) |
| Amgen Inc. | $244.69 | 11 | $0 (2023) |
| PFIZER INC. | $231.49 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $205.76 | 20 | $0 (2024) |
| LivaNova USA, Inc. | $179.56 | 6 | $0 (2024) |
| UCB, Inc. | $147.71 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,601 | 95 | ABBVIE INC. ($604.69) |
| 2023 | $971.84 | 43 | ABBVIE INC. ($308.86) |
| 2022 | $1,242 | 46 | ABBVIE INC. ($440.31) |
| 2021 | $1,596 | 99 | Biogen, Inc. ($704.05) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Neuroscience | ||||||
| 12/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| 11/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $100.11 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Neurology | ||||||
| 10/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Neurology | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $9.59 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/24/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Neurology | ||||||
| 09/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 413 | 17,648 | $461,992 | $135,465 |
| 2022 | 7 | 410 | 13,971 | $288,042 | $113,718 |
| 2021 | 6 | 321 | 5,976 | $162,897 | $53,246 |
| 2020 | 4 | 223 | 304 | $53,975 | $16,939 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 17,000 | $289,000 | $84,183 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 439 | $111,223 | $33,125 | 29.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 27 | 85 | $25,925 | $7,458 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $18,867 | $5,251 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 28 | $9,996 | $3,280 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 39 | $6,981 | $2,168 | 31.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 27 | 13,400 | $162,400 | $65,342 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 327 | $63,768 | $26,063 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $29,842 | $10,790 | 36.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 27 | 68 | $19,460 | $6,651 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 52 | $6,858 | $2,743 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,591 | $1,451 | 40.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,123 | $677.40 | 31.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 5,600 | $89,200 | $27,068 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 128 | $25,510 | $10,482 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 161 | $22,110 | $7,877 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,237 | $2,981 | 36.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 11 | 28 | $11,430 | $2,625 | 23.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $6,410 | $2,213 | 34.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 100 | $20,400 | $6,573 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 100 | 152 | $20,976 | $6,529 | 31.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 35 | 35 | $7,210 | $2,217 | 30.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,389 | $1,620 | 30.1% |
About Ashley Brewster
Ashley Brewster is a Family healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1962960708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Brewster has received a total of $6,411 in payments from pharmaceutical and medical device companies, with $2,601 received in 2024. These payments were reported across 283 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,411).
As a Medicare-enrolled provider, Brewster has provided services to 1,367 Medicare beneficiaries, totaling 37,899 services with total Medicare billing of $319,368. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location North Kansas City, MO
- Active Since 03/12/2019
- Last Updated 09/22/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1962960708
Products in Payments
- TYSABRI (Biological) $853.30
- QULIPTA (Drug) $634.24
- UBRELVY (Drug) $507.77
- EMGALITY (Drug) $406.01
- NURTEC ODT (Drug) $358.69
- BOTOX (Biological) $256.16
- Aimovig (Biological) $234.86
- VYEPTI (Biological) $209.05
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $179.56
- Austedo XR (Drug) $164.70
- KESIMPTA (Drug) $149.16
- KISUNLA (Drug) $143.40
- AUBAGIO (Drug) $138.04
- AJOVY (Biological) $130.32
- BRIUMVI (Drug) $124.55
- BAFIERTAM (Drug) $98.15
- VYVGART HYTRULO (Drug) $81.79
- Leqembi (Drug) $81.70
- Nourianz (Drug) $78.00
- PURIFIED CORTROPHIN GEL (Drug) $77.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in North Kansas City
Christina Coulson, Fnp, FNP
Family — Payments: $8,051
Tessa Weigel
Family — Payments: $4,150
Mrs. Carma Ball, Fnp-C, FNP-C
Family — Payments: $2,914
Suzanne Savage, Fnp-Bc, FNP-BC
Family — Payments: $1,533
Allyssa Plymell, Fnp-C, FNP-C
Family — Payments: $1,389
Mrs. Eleece Kaiser, Fnp-C, FNP-C
Family — Payments: $1,258